Filip Dubovsky - Jun 17, 2024 Form 4 Insider Report for NOVAVAX INC (NVAX)

Role: President, R&D
Signature: /s/Mark J. Casey, Attorney-in-Fact
Stock symbol: NVAX
Transactions as of: Jun 17, 2024
Transactions value $: -$201,164
Form type: 4
Date filed: 6/20/2024, 05:08 PM
Previous filing: May 15, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership
transaction	NVAX	Common Stock	Options Exercise	$9.79K	+1.4K	+2.11%	$6.97	68K	Jun 17, 2024	Direct
transaction	NVAX	Common Stock	Options Exercise	$76.1K	+12.5K	+18.38%	$6.09	80.5K	Jun 17, 2024	Direct
transaction	NVAX	Common Stock	Sale	-$181K	-12.5K	-15.52%	$14.46	68K	Jun 17, 2024	Direct
transaction	NVAX	Common Stock	Sale	-$20.4K	-1.4K	-2.06%	$14.54	66.6K	Jun 17, 2024	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	NVAX	Stock Option (Right to Buy)	Options Exercise	-$9.79K	-1.4K	-2.94%	$6.97	46.3K	Jun 17, 2024	Common Stock	1.4K	$6.97	Direct	F1
transaction	NVAX	Stock Option (Right to Buy)	Options Exercise	-$76.1K	-12.5K	-25%	$6.09	37.5K	Jun 17, 2024	Common Stock	12.5K	$6.09	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Twenty-five percent (25%) of the shares subject to this option granted under the Novavax, Inc. Amended and Restated 2015 Stock Incentive Plan, as amended, vest on the first anniversary of the grant date, and the remaining seventy-five percent (75%) of the shares vest in equal monthly installments over the following three (3) years, in each case subject to continued employment with the Company through such vesting date.

Content

Twenty-five percent (25%) of the shares subject to this option granted under the Novavax, Inc. Amended and Restated 2015 Stock Incentive Plan, as amended, vest on the first anniversary of the grant date, and the remaining seventy-five percent (75%) of the shares vest in equal monthly installments over the following three (3) years, in each case subject to continued employment with the Company through such vesting date.